A. Serrano

发表

Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin

Dharmesh D. Bhuva, Melissa J. Davis, Joseph Cursons, 2022, Cancers.

Mastering the use of cellular barcoding to explore cancer heterogeneity

S. Naik, J. Berthelet, D. Merino, 2022, Nature Reviews Cancer.

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

J. Visvader, T. Schumacher, G. Smyth, 2019, Nature Communications.

Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer

J. Visvader, G. Smyth, G. Dewson, 2017, Science Translational Medicine.

Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

J. Visvader, T. Schumacher, G. Smyth, 2019, Nature Communications.

The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile

Melissa J. Davis, K. Rogers, A. Papenfuss, 2021, Science Advances.

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

Daniel L. Cameron, J. Visvader, T. Schumacher, 2019, Nature Communications.

Experimental and spontaneous metastasis assays can result in divergence in clonal architecture

J. Mariadason, S. Naik, C. Ginestier, 2023, Communications biology.